June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Long term outcomes of lens clarity following lens-sparing vitrectomy for retinopathy of prematurity
Author Affiliations & Notes
  • Eric Nudleman
    Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, MI
  • Antonio Capone
    Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, MI
  • Kimberly Drenser
    Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, MI
  • Michael Trese
    Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, MI
  • Footnotes
    Commercial Relationships Eric Nudleman, None; Antonio Capone, Alcon Laboratories, Inc. (C), Alimera Sciences (C), Allergan, Inc. (C), Allergan, Inc. (F), FocusROP, LLC (P), FocusROP, LLC (I), GENENTECH (C), GENENTECH (F), GlaxoSmithKline (F), Ophthotec (F), Retinal Solutions, LLC (I), Retinal Solutions, LLC (P), Synergetics, Inc. (C), Thrombogenics (F); Kimberly Drenser, None; Michael Trese, Nu-Vue Technologies (P), Synergetics (C), Thrombogenics (I), Genentech (R), Focus ROP (I), Retinal Solutions LLC (I)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4946. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Eric Nudleman, Antonio Capone, Kimberly Drenser, Michael Trese; Long term outcomes of lens clarity following lens-sparing vitrectomy for retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4946. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: This study aimed to evaluate the long term outcomes on lens status of lens-sparing vitrectomy surgery for retinopathy of prematurity (ROP) associated retinal detachments.

Methods: Retrospective review of 220 eyes (158 patients) who underwent lens-sparing vitrectomy surgery for stage 4A, stage 4B and stage 5 ROP from 1994-2012. Lens clarity was evaluated from the most recent office visit or exam under anesthesia. In addition, success rates of surgeries were calculated based on rate of re-attachment and need for additional retinal surgeries. Visual acuity, refractive outcomes, and rate of glaucoma were also evaluated.

Results: Visually significant cataract formation was seen in 3 of 220 eyes (1.36%) following lens-sparing vitrectomy. Mean follow up was 3.2 years (range 64 days - 18 years). Forty nine eyes (22%) required lensectomy following lens-sparing vitrectomy due to progression of retinal traction and need for additional retinal surgery. Additional retinal surgeries were performed in 11% of eyes with stage 4A, 40% with stage 4B, and 82% with stage 5. Forty two eyes (19.0%) required drops to control intraocular pressure.

Conclusions: Here we present the largest series and the longest follow-up to date of outcomes following lens-sparing vitrectomy for ROP. We found the rate of cataract formation to be approximately one percent. Success rates for retinal re-attachement with a single surgery was approximately 89% for stage 4A, 60% for stage 4B and 18% for stage 5.

Keywords: 706 retinopathy of prematurity • 762 vitreoretinal surgery  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×